October 2026
1. DING W, Ji R, Pang C, Li J, et al
   Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis.
   Radiology. 2026;321:e260918.
   

   >> Share

   
   
2. SERAI SD, Pepin K, Chen J, Venkatesh SK, et al
   Standardizing Liver MR Elastography: Guidelines for Reliable Stiffness Measurement in Chronic Liver Disease.
   Radiology. 2026;321:e260974.
   

   >> Share

   
   
3. SHAFAAT O, Reis SP
   Implications for Hepatocellular Carcinoma Ablation beyond the Tumor Margin: An Early Career Perspective.
   Radiology. 2026;321:e262757.
   

   >> Share

   
   September 2026
4. AVRITSCHER R, Kim E, Chew V, Abou-Alfa GK, et al
   Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for (90)Y Radioembolization with Immunotherapy in HCC.
   Radiology. 2026;320:e251415.
   

   >> Share

   
   
5. LUO S, Wei X, Lu X, Wang Z, et al
   Histotripsy for Hepatocellular Carcinoma: From Bench to Bedside.
   Radiology. 2026;320:e254050.
   

   >> Share

   
   
6. HAIDEY J, Qian XJ, Wilson MP, Low G, et al
   Case 354.
   Radiology. 2026;320:e260544.
   

   >> Share

   
   August 2026
7. WU X, Li J, Deng R, Xu X, et al
   Photon-counting CT Extracellular Volume Fraction for Liver Fibrosis Assessment: Validation against MR Elastography and Histopathology.
   Radiology. 2026;320:e253979.
   

   >> Share

   
   
8. YOO JS, Tak KY, Cho HS, Han JW, et al
   Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.
   Radiology. 2026;320:e253280.
   

   >> Share

   
   
9. DEYIRMENDJIAN C, Tang A
   Hepatic Arterial Infusion Chemotherapy as Second-line Therapy in Advanced Hepatocellular Carcinoma: An Early Career Perspective.
   Radiology. 2026;320:e262083.
   

   >> Share

   
   July 2026
10. JEON SK, Joo I, Kang HJ, Kim JH, et al
    Noncontrast Abbreviated MRI for Post-TACE Treatment Response Monitoring of Hepatocellular Carcinoma Based on Ancillary Features from LI-RADS.
    Radiology. 2026;320:e252803.
    

    >> Share

    
    
11. PARAMESWARAN M, Baikpour M, Hunt DT, Orlowski M, et al
    Best Practice: Implementation of Liver US Shear-Wave Elastography in Clinical Practice.
    Radiology. 2026;320:e252544.
    

    >> Share

    
    
12. LEE L, Lee J, Hao F, Lee EW, et al
    Robotic-assisted (90)Y Transarterial Radioembolization for Treatment of Hepatocellular Carcinoma: Initial Experience.
    Radiology. 2026;320:e253870.
    

    >> Share

    
    
13. KIM J, Kim JH, Ko E, Kim JY, et al
    Endovascular Treatment of Intrahepatic Hepatic Artery Pseudoaneurysms: Safety and Efficacy According to Embolization Strategies.
    Radiology. 2026;320:e252859.
    

    >> Share

    
    June 2026
14. SHIN J, Yoo J, Gu K, Baek SY, et al
    Evaluating Accuracy of LI-RADS Nonradiation Treatment Response Algorithm v2024 and Ancillary Features at Hepatobiliary MRI versus CT.
    Radiology. 2026;319:e253143.
    

    >> Share

    
    
15. HEO S, Jung YJ, Choi ES, Kim S, et al
    Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.
    Radiology. 2026;319:e253854.
    

    >> Share

    
    
16. LI J, Pang C, Li H, Liu G, et al
    Sequencing Ablation and Systemic Therapy in Colorectal Liver Oligometastases: An Upfront versus Delayed Approach Nationwide Analysis.
    Radiology. 2026;319:e251003.
    

    >> Share

    
    May 2026
17. BERMAN ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, et al
    Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e251923.
    

    >> Share

    
    
18. BRUNSING RL, Syed AB, Hargreaves BA, Ennis DB, et al
    Diffusion-weighted Imaging of the Liver: Primed for New Business.
    Radiology. 2026;319:e250157.
    

    >> Share

    
    
19. WANG TC, Wei N, Bao Y, Li JX, et al
    CT Radiomics-based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e250736.
    

    >> Share

    
    
20. MITTELSTEIN DR, Khurana A, Vodkin I, Vavinskaya V, et al
    Interobserver Agreement in Contrast-enhanced US for Hepatic Nodules in Patients with Fontan-associated Liver Disease.
    Radiology. 2026;319:e252622.
    

    >> Share

    
    April 2026
21. MENG F, Teng Y
    Abernethy Malformation Type I with Multiple Hepatic FNH/NRH.
    Radiology. 2026;319:e252981.
    

    >> Share

    
    March 2026
22. CHOI ES, Koo B, Kim S, Song IH, et al
    MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.
    Radiology. 2026;318:e252611.
    

    >> Share

    
    
23. LI Y, Lu S, Mao S, Li Q, et al
    Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018.
    Radiology. 2026;318:e252271.
    

    >> Share

    
    
24. KUHNEL C, Schmidt TN, Freesmeyer M, Schricke M, et al
    Transarterial Radioembolization: Medical Staff Dosimetry for (90)Y-Resin, (90)Y-Glass, and (166)Ho-PLLA Microspheres.
    Radiology. 2026;318:e251822.
    

    >> Share

    
    
25. DOPPELT G, Occean BV, Fabbro-Peray P, Haefliger L, et al
    The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years.
    Radiology. 2026;318:e251517.
    

    >> Share

    
    
26. DIMOPOULOS MP, Sotirchos VS, Vakiani E, Sigel C, et al
    Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial).
    Radiology. 2026;318:e250864.
    

    >> Share

    
    
27. CENTNER CS, Choi R, Georgiades CS, Yarchoan M, et al
    Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
    Radiology. 2026;318:e250263.
    

    >> Share

    
    
28. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
    Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
    Radiology. 2026;318:e252892.
    

    >> Share

    
    February 2026
29. QI BN, Zhao XY, Lv WJ, Shan S, et al
    Nodular Transformation-driven Circulatory Remodeling in Biliary Atresia-induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering.
    Radiology. 2026;318:e252332.
    

    >> Share

    
    
30. LEWIS S, Wildman-Tobriner B, Cuevas J, Calle S, et al
    Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis.
    Radiology. 2026;318:e251497.
    

    >> Share

    
    
31. KIM TH, Harding JJ, Chernyak V, Mendiratta-Lala M, et al
    How I Do It: Systemic Therapies for Primary Liver Cancers.
    Radiology. 2026;318:e251371.
    

    >> Share

    
    January 2026
32. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    

    >> Share

    
    
33. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    

    >> Share

    
    
34. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    

    >> Share

    
    
35. CHENG MQ, Hu HT, Wu SH, Huang H, et al
    Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance.
    Radiology. 2026;318:e252252.
    

    >> Share

    
    
36. DAGGUMATI L, Stark L, Booth AL, Fraum TJ, et al
    Case 344: Hepatic Epithelioid Hemangioendothelioma.
    Radiology. 2026;318:e251815.
    

    >> Share

    
    
37. MATTEINI F, Vilgrain V
    Isolated Hepatic Mucormycosis in Acute Lymphoblastic Leukemia.
    Radiology. 2026;318:e252306.
    

    >> Share

    
    December 2025
38. ZHU L, Jiang B, Fei X, Xu Y, et al
    Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.
    Radiology. 2025;317:e251698.
    

    >> Share

    
    
39. XIAO Z, Liu X
    Hepatocellular Carcinoma Presenting as Bile Duct Tumor Thrombus without Obvious Intrahepatic Mass.
    Radiology. 2025;317:e251418.
    

    >> Share

    
    November 2025
40. YU SCH, Chan L, Lee KF, Cho CCM, et al
    Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion.
    Radiology. 2025;317:e242982.
    

    >> Share

    
    
41. PARK R, Choi ES, Byun JH, Won HJ, et al
    Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.
    Radiology. 2025;317:e251598.
    

    >> Share

    
    October 2025
42. DENG M, Li Z, Sun L, Wang H, et al
    Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study.
    Radiology. 2025;317:e250026.
    

    >> Share

    
    
43. FOWLKES JB
    Microbubbles, Ultrasound, and Radiation: Finding the Treatment Synergy for Hepatocellular Carcinoma.
    Radiology. 2025;317:e252815.
    

    >> Share

    
    September 2025
44. WESSNER CE, Forsberg F, Lyshchik A, O'Kane P, et al
    Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.
    Radiology. 2025;316:e250083.
    

    >> Share

    
    August 2025
45. CANNELLA R
    MRI Quantitative Features: A Bridge to Hepatocellular Carcinoma Tumor Profiling.
    Radiology. 2025;316:e252216.
    

    >> Share

    
    
46. MATUSCHEWSKI NJ, Sobirey R, Revzin M, Zeevi T, et al
    Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2025;316:e242750.
    

    >> Share

    
    
47. XIA H, Min Y, Wang Y, Gao S, et al
    Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
    Radiology. 2025;316:e243780.
    

    >> Share

    
    July 2025
48. ABEDRABBO N, Lam ET, McInnes MDF, Dawit H, et al
    Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis.
    Radiology. 2025;316:e242278.
    

    >> Share

    
    
49. LEWANDOWSKI RJ, Serhal M, Padia SA, Kim E, et al
    The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy.
    Radiology. 2025;316:e240333.
    

    >> Share

    
    
50. HUANG TY, Li ZY, Tian J, Xie XJ, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease at Quantitative US: International Prospective Study.
    Radiology. 2025;316:e242564.
    

    >> Share

    
    
51. ZHANG W, Shen G
    Hepatic Langerhans Cell Histiocytosis Revealed at FAPI PET/CT.
    Radiology. 2025;316:e243458.
    

    >> Share

    
    
52. REA B, Blakeborough A
    Case 339: Hepatobiliary Contrast Agent Uptake in an Adrenal Metastasis from Hepatocellular Carcinoma.
    Radiology. 2025;316:e242718.
    

    >> Share

    
    June 2025
53. ADAMO RG, van der Pol CB, Alabousi M, Lam E, et al
    Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis.
    Radiology. 2025;315:e243450.
    

    >> Share

    
    May 2025
54. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    

    >> Share

    
    April 2025
55. WU H, Zhu Z, Li J, Qiu C, et al
    Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
    Radiology. 2025;315:e242349.
    

    >> Share

    
    
56. QIU C
    US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go.
    Radiology. 2025;315:e242559.
    

    >> Share

    
    
57. GUO X, Zhou Y
    Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula.
    Radiology. 2025;315:e242069.
    

    >> Share

    
    March 2025
58. LEE S, Yoon JK, Shin J, Shin H, et al
    US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis.
    Radiology. 2025;314:e240450.
    

    >> Share

    
    
59. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    

    >> Share

    
    
60. REA B, Blakeborough A
    Case 339.
    Radiology. 2025;314:e242717.
    

    >> Share

    
    
61. AN J, Park R, Kim E, Na SK, et al
    LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.
    Radiology. 2025;314:e241856.
    

    >> Share

    
    
62. SCHOLLNAST H
    Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C.
    Radiology. 2025;314:e250627.
    

    >> Share

    
    February 2025
63. ZHANG YJ, Chen J, Zhou Z, Hu D, et al
    Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
    Radiology. 2025;314:e241096.
    

    >> Share

    
    
64. ZHANG K, He K, Zhang L, Li WC, et al
    Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma.
    Radiology. 2025;314:e233229.
    

    >> Share

    
    
65. RONOT M
    Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy.
    Radiology. 2025;314:e243768.
    

    >> Share

    
    
66. BITAR R, Salem R, Finn R, Greten TF, et al
    Erratum for: Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2025;314:e259004.
    

    >> Share

    
    January 2025
67. WILDMAN-TOBRINER B, Felice N, Kalisz KR, Allen BC, et al
    Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
    Radiology. 2025;314:e241568.
    

    >> Share

    
    
68. LYSHCHIK A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, et al
    Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI.
    Radiology. 2025;314:e240916.
    

    >> Share

    
    
69. LI W, Lv J, Li H, Song L, et al
    Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging.
    Radiology. 2025;314:e241275.
    

    >> Share

    
    December 2024
70. KAMAYA A, Fetzer DT, Seow JH, Burrowes DP, et al
    LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS.
    Radiology. 2024;313:e240169.
    

    >> Share

    
    
71. JANG HJ, Choi SH, Wee S, Choi SJ, et al
    CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
    Radiology. 2024;313:e240961.
    

    >> Share

    
    November 2024
72. HAGHSHOMAR M, Antonacci D, Smith AD, Thaker S, et al
    Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
    Radiology. 2024;313:e241171.
    

    >> Share

    
    
73. JIANG H, Cannella R, Wu Z, Beaufrere A, et al
    Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
    Radiology. 2024;313:e233471.
    

    >> Share

    
    
74. HARMATH C
    Hepatocellular Carcinoma: The Meaning of Intratumoral Fat Patterns in Different Patient Populations.
    Radiology. 2024;313:e242740.
    

    >> Share

    
    
75. LAI B, Zhong J
    Hepatic Langerhans Cell Histiocytosis.
    Radiology. 2024;313:e241037.
    

    >> Share

    
    
76. ASLAM A, Chernyak V, Miller FH, Bashir M, et al
    CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
    Radiology. 2024;313:e232408.
    

    >> Share

    
    
77. BITAR R, Salem R, Finn R, Greten TF, et al
    Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2024;313:e232875.
    

    >> Share

    
    October 2024
78. RIEDEL C, Hoffmann M, Ismahil M, Lenz A, et al
    Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt.
    Radiology. 2024;313:e232989.
    

    >> Share

    
    
79. MATOS C, Metens T
    Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.
    Radiology. 2024;313:e242548.
    

    >> Share

    
    
80. ZHANG L, Long X, Chen L, Han X, et al
    Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.
    Radiology. 2024;313:e240343.
    

    >> Share

    
    
81. CAO J, Mroueh N, Mercaldo N, Lennartz S, et al
    Detectability of Hypoattenuating Liver Lesions with Deep Learning CT Reconstruction: A Phantom and Patient Study.
    Radiology. 2024;313:e232749.
    

    >> Share

    
    
82. MOTOSUGI U, Watanabe H
    Navigating Hemodynamic Insights: A Promising Future with Four-dimensional Flow MRI and Computational Fluid Dynamics in Transjugular Intrahepatic Portosystemic Shunt Management.
    Radiology. 2024;313:e241857.
    

    >> Share

    
    
83. FERRAIOLI G, Roccarina D, Barr RG
    Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
    Radiology. 2024;313:e240162.
    

    >> Share

    
    September 2024
84. MENDIRATTA-LALA M, Wiggermann P, Pech M, Serres-Creixams X, et al
    The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.
    Radiology. 2024;312:e233051.
    

    >> Share

    
    
85. PIERCE TT, Ozturk A, Sherlock SP, Moura Cunha G, et al
    Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.
    Radiology. 2024;312:e233094.
    

    >> Share

    
    
86. AHMED TM, Fishman EK
    Cinematic Rendering of Hepatic Hydatid Disease.
    Radiology. 2024;312:e240527.
    

    >> Share

    
    
87. WILDMAN-TOBRINER B
    Photon-counting Detector CT: A Promising Tool for Noninvasive Liver Fat Assessment.
    Radiology. 2024;312:e241963.
    

    >> Share

    
    
88. LIN H, Xu X, Deng R, Xu Z, et al
    Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e240038.
    

    >> Share

    
    August 2024
89. SUGIMOTO K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, et al
    US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
    Radiology. 2024;312:e233377.
    

    >> Share

    
    
90. YIN M
    Shear-Wave Dispersion for Detecting Hepatic Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e241420.
    

    >> Share

    
    
91. CHEUNG CL, Tripathi V, Chiang CL, Chiu KWH, et al
    Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5.
    Radiology. 2024;312:e240056.
    

    >> Share

    
    June 2024
92. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    

    >> Share

    
    
93. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    

    >> Share

    
    May 2024
94. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    

    >> Share

    
    
95. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    

    >> Share

    
    
96. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    

    >> Share

    
    
97. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    

    >> Share

    
    
98. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    

    >> Share

    
    
99. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    

    >> Share

    
    April 2024
100. YOON JH, Kim YK, Kim JW, Chang W, et al
     Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
     Radiology. 2024;311:e233114.
     

     >> Share

     
     
101. LEE Y, Kim NH, Kang JH, Cho YS, et al
     Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
     Radiology. 2024;311:e232188.
     

     >> Share

     
     
102. LYU L, Xu P
     Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
     Radiology. 2024;311:e232426.
     

     >> Share

     
     
103. GHOSH A
     B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
     Radiology. 2024;311:e240868.
     

     >> Share

     
     
104. ZENG QQ, Liang P
     Super-Resolution US Imaging of Focal Nodular Hyperplasia.
     Radiology. 2024;311:e233130.
     

     >> Share

     
     
105. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
     US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
     Radiology. 2024;311:e231461.
     

     >> Share

     
     March 2024
106. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
     Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
     Radiology. 2024;310:e231220.
     

     >> Share

     
     
107. LIU F, Bi M, Jing X, Ding H, et al
     Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
     Radiology. 2024;310:e232416.
     

     >> Share

     
     
108. REUTER KL
     Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
     Radiology. 2024;310:e240436.
     

     >> Share

     
     February 2024
109. CHAPIRO J
     Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
     Radiology. 2024;310:e240072.
     

     >> Share

     
     
110. AUER TA, Muller L, Schulze D, Anhamm M, et al
     CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
     Radiology. 2024;310:e232044.
     

     >> Share

     
     
111. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
     Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
     Radiology. 2024;310:e232365.
     

     >> Share

     
     
112. GEMMETE JJ
     Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
     Radiology. 2024;310:e240015.
     

     >> Share

     
     
113. CRIVELLARO P
     A Deeper Look into Ancillary Features in LI-RADS Classification.
     Radiology. 2024;310:e240251.
     

     >> Share

     
     
114. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
     LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
     Radiology. 2024;310:e231501.
     

     >> Share

     
     
115. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
     Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
     Radiology. 2024;310:e231160.
     

     >> Share

     
     
116. KARTALIS N, Grigoriadis A
     LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
     Radiology. 2024;310:e240161.
     

     >> Share

     
     January 2024
117. MA L, Zhang W, Ma J, Luo J, et al
     Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
     Radiology. 2024;310:e232499.
     

     >> Share

     
     
118. TAN XZ, Chen X, Liu P
     Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
     Radiology. 2024;310:e232349.
     

     >> Share

     
     
119. KADI D, Loomba R, Bashir MR
     Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
     Radiology. 2024;310:e222695.
     

     >> Share

     
     
120. FOWLER KJ, Chernyak V
     What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
     Radiology. 2024;310:e232771.
     

     >> Share

     
     
121. DIETRICH CF
     Modified Algorithm for Contrast-enhanced US LI-RADS.
     Radiology. 2024;310:e232742.
     

     >> Share

     
     December 2023
122. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
     Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
     Radiology. 2023;309:e231656.
     

     >> Share

     
     
123. SIRLIN CB, Chernyak V
     Are We Ready to Simplify and Improve LI-RADS?
     Radiology. 2023;309:e233164.
     

     >> Share

     
     
124. TAMIR S, Tau N
     Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
     Radiology. 2023;309:e233123.
     

     >> Share

     
     
125. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
     Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222776.
     

     >> Share

     
     November 2023
126. JIANG H, Yang C, Chen Y, Wang Y, et al
     Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
     Radiology. 2023;309:e230527.
     

     >> Share

     
     
127. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
     Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222891.
     

     >> Share

     
     
128. TSAI R, Mellnick VM
     Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
     Radiology. 2023;309:e232480.
     

     >> Share

     
     
129. OZTURK A, Kumar V, Pierce TT, Li Q, et al
     The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
     Radiology. 2023;309:e223146.
     

     >> Share

     
     
130. TAN XZ, Liu P, Xiang H
     The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
     Radiology. 2023;309:e231141.
     

     >> Share

     
     October 2023
131. TUTHILL TA
     Advancing AI-assisted US Screening for Fatty Liver.
     Radiology. 2023;309:e232442.
     

     >> Share

     
     
132. HAN A
     Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
     Radiology. 2023;309:e232475.
     

     >> Share

     
     
133. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
     Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
     Radiology. 2023;309:e230659.
     

     >> Share

     
     
134. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
     Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
     Radiology. 2023;309:e230341.
     

     >> Share

     
     
135. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
     Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
     Radiology. 2023;309:e230727.
     

     >> Share

     
     
136. HEO S, Lee SS, Choi SH, Kim DW, et al
     CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
     Radiology. 2023;309:e231208.
     

     >> Share

     
     
137. FRAUM TJ
     CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
     Radiology. 2023;309:e232439.
     

     >> Share

     
     
138. XIA T, Du M, Li H, Wang Y, et al
     Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
     Radiology. 2023;309:e231007.
     

     >> Share

     
     
139. REEDER SB, Starekova J
     MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
     Radiology. 2023;309:e232552.
     

     >> Share

     
     
140. MONSELL SE
     Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
     Radiology. 2023;309:e232551.
     

     >> Share

     
     
141. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
     Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
     Radiology. 2023;309:e231092.
     

     >> Share

     
     
142. KOZAKA K, Matsui O
     MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
     Radiology. 2023;309:e232420.
     

     >> Share

     
     September 2023
143. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
     Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
     Radiology. 2023;308:e230709.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share